HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rongxing Liu Selected Research
Rongxing Liu Research Topics
Disease
6
Neoplasms (Cancer)
01/2024 - 11/2019
2
Hematologic Neoplasms (Hematological Malignancy)
06/2022 - 01/2021
2
Leukemia
01/2021 - 01/2019
1
Esophageal Squamous Cell Carcinoma
11/2023
1
Neoplasm Metastasis (Metastasis)
11/2023
1
Mouth Neoplasms (Oral Cancer)
01/2023
1
Lymphoma (Lymphomas)
06/2022
1
Obesity
06/2022
1
B-Cell Lymphoma (Lymphoma, B Cell)
06/2022
1
Autoimmune enteropathy
01/2022
1
Liver Neoplasms (Liver Cancer)
11/2019
Drug/Important Bio-Agent (IBA)
3
Protein Tyrosine Phosphatases
IBA
06/2022 - 01/2022
2
Enzymes
IBA
01/2021 - 01/2019
2
Etoposide (VP 16)
FDA Link
Generic
01/2021 - 01/2019
1
camrelizumab
IBA
11/2023
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2023
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
01/2023
1
Therapeutic Uses
IBA
12/2022
1
6-pyruvoyltetrahydropterin synthase (PTPS)
IBA
06/2022
1
Lipids
IBA
11/2019
1
Quinoxalines
IBA
11/2019
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
11/2019
1
Sincalide
FDA Link
11/2019
1
quinone (benzoquinone)
IBA
01/2019
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
01/2019
Therapy/Procedure
2
Therapeutics
01/2024 - 01/2021
1
Neoadjuvant Therapy
11/2023
1
Drug Therapy (Chemotherapy)
12/2022